#Researcher S's recovery

[heaven-s-black-box]

Normal- Lyney x Neuvillette's child!Reader

Return to File

Recovery date: April 27th, 2024

Description: Hello it's me, sorry if this is a bad time, but I got inspired by Arlecchino's story quest, and I wondered about combining that with my previous two requests about the reader being Neuvillette's child, this is mainly just an idea so if you're not comfortable with writing this that's completely alright.

Notes: This work was recovered in conjunction with @crystalkat6747, we thank her for her contribution. Ahh, I actually finished the story quest the day before you sent this request, lol.

Part: 1 2 3 4 (Can be read alone)

Word count: 810

Back to directory

Lyney watches the moon’s light drift across the ceiling. Lynette is curled up against one side and Freminet is curled up against the other, both sound asleep after their return to the house. He watches their lashes flutter against their cheeks, eyes flicking back and forth behind their eyelids as they dream. Pleasant dreams, he hopes.

He turns back to the ceiling and chokes down a breath as Lynette’s head presses against his ribs awkwardly. His wounds from their fight with father were mostly healed, but still tender. She shifts off him again quickly, eyes opening briefly as if she could sense his distress.

The long shadows continue to dance above them as Lyney's thoughts drift back to the fight.

As for whether to take them, the choice is yours.

Carefully, Lyney slips his arms out from under and around his siblings and inches towards the foot of the bed. Almost as soon as he’s climbed out, Lynette and Freminet roll towards each other and grab on to each other's hands. It makes him smile, the way they take comfort in each other, like a family.

The streets are empty and dimly lit as he makes his way through the court. He eventually finds himself in front of a familiar house and rounds the side to climb up to Y/n’s window. Their curtains are tied back, and he just sits in the tree for a while watching them.

On their bedside table, he sees the rainbow roses he’d given them on their first date a week ago. Next to those is a little penguin, an otter, and two cat mechanisms that Freminet had gifted them for their last birthday. They looked like a little family.

A clicking noise and the swishing of the window opening startled him.

“Ly-Lyney?” Y/n yawned. “What are you doing here?”

He blinked owlishly.

“I…”

Y/n stared back at him for a moment before backing up and waving him in. They sat back against the headboard of their bed and Lyney crawled next to them, curling against their side.

“You wanna talk about it?” They whispered, arm wrapped around Lyney’s shoulder.

“We can’t have a normal life,” Lyney said, staring at the mechanisms on their bedside table. “I mean, I can’t have a normal life. Not as a member of the house of the hearth, and that means that we- OW!” 

He hissed as Y/n pinched his arm. They cupped his chin and forced him to look up at them.

“I love you. I don’t care what our normal looks like, if it doesn’t look like everyone else's then so be it.” Lyney blinked up at them, cheeks turning red. There was a small frown tugging at the corner of their lips as they continued. “What brought this up anyways?” Lyney chewed at his lip. “Is this about that proposal for former House of the Hearth members?”

The magician’s eyes widened in surprise.

“How did you-”

“My father wanted my opinion,” they shrugged, letting go of his chin.

Lyney slumped back against their shoulder and laced his fingers with theirs. In turn, they hooked one of their legs through his so they were wrapped up in eachother.

“The House of the Hearth is my family, but the other day… it gave me a lot to think about. I could leave at the cost of my current self, not that I want to but it’s never seemed like an option before.We’re preparing for a dangerous mission with other Harbingers, and father wants me to be the next king. I know this was never going to be normal but for just a moment I imagined what it would be like if we were.”

“Do you want to talk about it?” Y/n offered again.

Lyney squeezed their hand.

“If I left the house, would you come find me again?”

“Always.”

“And if I die on this mission, would you miss me? Would you be there for Lynette and Freminet?”

“Dying, will not get you out of this relationship, and bold of you to assume those two will let you die without them.”

Lyney let out a snort of amusement while Y/n smirked.

“And if I became the King of the house?”

“Lyney, I’m not leaving you.” They leaned their head against his. “I may not know what exactly is going on, but I love you, and I’ll stand by you no matter what you decide. I never expected you to leave the house, and part of what I love so much about you is your dedication to your family.”

Y/n looked down, finding Lyney’s eyes and offering him a loving smile.

Lyney’s eyes caught once more on the little family diorama on their bedside table before he looked back at them and squeezed their hand again.

“Then will you marry me?”

[eiraeths]

in the medically discharged soap au im working on i wanna make him have dysautonomia. like he loses his left leg below the knee thats gotta fuck with your ans somehow. plus i have dysautonomia and i think the way it interacts with the pns and sns would be cool to explore not cool but like good?? not good its bad but like i want to inflict pain and having a disorder that makes your autonomic nervous system suck paired with ptsd which makes your nervous system hyperactive theres gotta be something there. does this make sense? i probably need to write this down in a clear way before i actually implement it into the story

[malasquid]

So. I've Cracked The Code On The Appearance Changes in Side Order.

Wall of photos and such incoming.

After a lot of testing, I've discovered there are 7 different little lights and doodads that are added to Agent 8 via upgrading certain chips, each with a basic 1st tier and and upgraded 2nd tier. The 1st tier of upgrades appear after picking up two of the same chips in that changes pool (ex: 2 Homing Shots chips), with the 2nd tier appearing after picking up five of them (ex: 5 Homing Shot chips). There is no further visual indicators added for maxing chips that go beyond 5, such as Splash Damage or Rush Attack.

Full disclaimer: This is the result of researching a LOT of my own runs, so I can say this is true with about 95% certainty. If I labeled an ability chip in the wrong visual pool, please let me know!

Let's start with the basics - our control group. No Teal upgrades provide any visible changes to Agent 8 (or Pearl-bot for that matter), so I ran an all-teal palette to demonstrate.

First is likely one of the more requested visual changes - the Headset. The 1st tier sports a basic metallic earpiece, with the 2nd adding an antenna and eyepiece that match your primary ink color.

Maxing Splash Damage, Sound Wave Damage, Splash Radius, Special Charge Up, Turf Lucky Chain, Rush Knockback, and Homing Shots all provide the headset!

Next up is Ink Bubbles. The 1st tier shows transparent, slower bubbles flowing in 8's ink tank, with the bubbles being faster and more opaque in the 2nd tier.

Nabbing Poison Ink, Splat Ink Recovery, Ink Saver Sub, Ink Recovery Rate, Sticky Ink, and Explosion Knockback all provide Ink Bubbles.

Following that is the Fins. The 1st tier shows the base shackles being added to 8's boots, with the fins themselves being added for the 2nd tier.

Picking up Run Speed, Swim Speed, Rush Attack, Mobile Ink Recovery, Mobile Special Charge, and Mobile Drone Gauge all provide the Fins.

Now, moving on to the weapon upgrades!

First we have the Muzzle Lights, which appear at the muzzle of most weapons, and the sides of the brush and roller nearest the base. The 1st tier shows a circle and squares circling around the muzzle, with the 2nd tier being more exaggerated, with alternating squares and rectangles forming a hexagon pattern in the center.

These are exclusive to the Ink Damage, Main Damage (Close), and Main Damage (Distant) chips.

Next up is likely the most common visual one can see on their run - the Arrows. The 1st tier shows a circle with three arrows pointing down the weapon, with the 2nd tier adding some blowback markers behind the circle.

These are on a whopping TEN upgrades, being Splatling Barrage, Main Firing Speed, Horizontal Slash Speed, Main Range, Main Piercing, Main Ink Coverage, Rush Ink Coverage, Quick Charge, Shot Spread Reduction, and Ink Saver Main.

Last of the weapon upgrades are the Dots. The 1st tier is 3 large dots and a circle spinning at the bottom of your weapon or around your wrist, with the 2nd tier adding another circle around the dots.

These can be found on the Hindrance Damage, Ink Attack Size, Charge Storage, Moving Ink Speed, Extra Dodge Roll, Brella Cooldown, and Knockback upgrades.

And finally, my favorite little knick-knack, the Shrimp Hook. This little guy appears on your ink tank after picking up 2 matching Luck upgrades (ex: Lucky Bomb Drop, Canned Special Drop, etc), and begins to glow after picking up 5. However, the glowing effect is not visible in the post-game screen. 😔 (I would totally buy one of these if someone made one, btw)

By the way, 7 visual upgrades * 5 chips needed to max each visual is 35 chips, which is just shy of the 36 total chips you can have on one palette, which means, in theory, you could. Have every maxed visual indicator on in one run.

Just a thought. : )

[zillychu]

I’ve gotten a WAVE of asks about this AU, so I decided to flesh it out some more and answer some of those questions!

I’ll probably polish this extended summary up at some point and submit it to AO3. But for now, here’s a rundown of my thoughts–please feel free to send more questions! I’ll update this post if I get any more. But if you’re someone who wanted to write fic for it, don’t worry, you don’t need to take my headcanons as gospel. It’s a pretty basic AU honestly lol

Summary:

The portal accident results in a violent explosion that wipes out the whole block, and condemns all of Amity Park. Danny haunts the city for 100 years, before Sam and Tucker find him. 

Setup:

In the 1920’s, 19-year-old Danny went into the incomplete portal on his own, hoping to help out his parents. Ripping the portal open through unnatural means created a huge burst of energy that resulted in a massive explosion. A good portion of the Amity Park population died, many were injured, and the ones on the fringes relocated–Amity was quickly deemed too dangerous due to the excess ectoplasm in the area that attracted ghosts. 

While the disaster was in Amity, the fallout was seen around the globe. Before, natural portals were rare, short-lived, and rarely allowed ghosts to fully slip into our realm (the most severe cases being on par with poltergeists that most people didn’t believe in). Now, natural portals pop open frequently around the world, large enough to allow the entirety of a ghost into the physical plane. They’re more common the closer you get to Amity, but they happen enough elsewhere that this change was something of a small apocalypse before people settled back down and found out how to combat at least some of their new, permanent neighbors. 

Danny is unaware that he’s only half-dead, believing he’s a full ghost. He ends up sticking around Amity, unintentionally making it his haunt. His grief and guilt over causing the death of his loved ones (and many others) makes him isolate and avoid human contact. Though he has, at times, scared nosy people away from the city in a mix of territorial instinct–and to get them to leave before a less friendly ghost finds them. 

Ghosts are much more of an uncontested danger in this AU. Lesser ghosts are practically mindless, and while stronger ghosts are capable of reason, their interests are limited. They’re highly territorial, possessive, and often destructive. Most worrisome is that they also like to snack on the life force of anything alive. No one is sure what dictates a ghost’s propensity to attack or hunt the living for their life force since ghosts don’t exactly experience hunger. At least, not the way we do. If a human is rescued before their life force is fully drained, they can make a full recovery–though humanity has still not yet found what this “life force" is. 

And since the Fentons’ research died along with them, there aren’t many tools available to the public to protect them from ghosts. Most homes have standard ghost shields and some weapons are available on the market, but certified ghost hunters are required to take care of anything more powerful than your average spook. 

Sam and Tucker met in high school, and are now rooming together for college very close to the Amity border. Rent is surprisingly cheap when you’re a stone’s throw away from a condemned area crawling with ghosts. Sam is the one who drags Tucker along with her fascination over finding out more about the city, and its largely mysterious demise. Sam is aware of the danger, but feels ghosts have a place in this world just like everything else, and does exercise caution–like one would while foraging in the woods with a known tiger population. 

What she and Tucker weren’t expecting was to run into a ghost that felt almost human. One that hasn't hurt them, not for lack of trying–while being powerful enough to walk past ghost shields without so much as a flinch. The long white hair is familiar in the whispers of the ectobiologist community, but there’s no way it could be the rumored ghost king Phantom, right?

About Danny:

He has very long hair, claws, and black sclera. His hazmat suit is more torn and ragged, with exposed hands and feet that fade into a burnt black.

His hair tends to float a lot on its own. It can start morphing into fire under duress. 

He does still technically have gloves and boots, they've just charred and melted into his skin towards the ends. He can't take them off in his ghost form. His hands and feet have a leathery texture that's tougher than the rest of his skin.

The white of his hazmat suit is both supposed to look like flames, and also a battered look representing his more violent, explosive death.

Overall, he appears rather listless and sad, with an unnerving air of danger around him–even for a ghost. 

Danny’s “ghost sense” comes out as white smoke.

He does breathe black smoke at times, usually when agitated. 

He's already fought and defeated Pariah Dark by the time Sam and Tucker find him, technically making him the Ghost King. This is heavily speculated by ghost experts, despite there being no real proof beyond a massive battle that scarred Illinois. He has not donned the Ring or the Crown, and captured sentient ghosts are hesitant to answer questions surrounding him. Danny basically has the throne but doesn’t do anything with it, and finds it meaningless enough to routinely forget he has the title. He only fought Pariah because he knew otherwise, humanity would have perished. A lot of ghosts are scared of him because he's so hard to figure out, and he's strong. 

Danny is usually very quiet and speaks softly, because his lungs were damaged in the blaze that half-killed him. He's technically healed since becoming a ghost, so it's more of a compulsion due to the traumatic memory. That, and he’s just… very forlorn and distant, shy around humans who don’t seem to understand how dangerous it is to keep hanging around him.

His memories pre-accident are extremely fuzzy. He knows the very basics of who he was, but specifics have been muffled due to trauma and isolation. He routinely forgets human habits, etiquette, etc. and tends to act more like a full ghost with some odd quirks. 

He does try to scare Sam and Tucker off numerous times. Unfortunately for him, they realized they shouldn't have been able to escape a ghost that strong–but they did, because he let them. 

Sam and Tucker think he's mute at first! He doesn't speak a word to them until several encounters later, when he fumbles his whole scary act and saves them from another ghost. 

He’s still half-ghost, though he doesn’t figure this out until Sam and Tucker come along trying to unravel the mysteries behind the Amity catastrophe. Physically and emotionally, he’s been stuck for 100 years–so his human form is still 19. It’s unclear at this point if he can age normally like a human as long as he stays in human form, or if he’s immortal. 

Danny's family did not turn into ghosts, though he sometimes worries he'll find them in the afterlife as shells of their former selves. He doesn't know if it's better or worse that he's not sure he'd recognize them. 

(Danny also still has some living family. Take a guess.)

Yes, he knows how to Wail. Understandably, he very rarely uses it. You do not want to witness this.

Danny :) is not immune :) from the allure of eating a human's life force :)))

[patbertram]

Body Farm

I’m reading a book about the body farm. In the first paragraph the name of the place was capitalized — Body Farm — and I wondered who Body was. In my mind, I pronounced it Bodie rather than Boddy, which mistake I immediately had to laugh at. I mean, I knew the book took place on The Body Farm. I knew it was a mystery written by the fellow who founded The Body Farm, and yet, there I sat,…

[reasonsforhope]

"Seven federal agencies are partnering to implement President Biden’s American Climate Corps, announcing this week they would work together to recruit 20,000 young Americans and fulfill the administration's vision for the new program. 

The goals spelled out in the memorandum of understanding include comprehensively tackling climate change, creating partnerships throughout various levels of government and the private sector, building a diverse corps and serving all American communities.

The agencies—which included the departments of Commerce, Interior, Agriculture, Labor and Energy, as well the Environmental Protection Agency and AmeriCorps—also vowed to ensure a “range of compensation and benefits” that open the positions up to a wider array of individuals and to create pathways to “high-quality employment.”  

Leaders from each of the seven agencies will form an executive committee for the Climate Corps, which Biden established in September, that will coordinate efforts with an accompanying working group. They will create the standards for ACC programs, set compensation guidelines and minimum terms of service, develop recruitment strategies, launch a centralized website and establish performance goals and objectives. The ACC groups will, beginning in January, hold listening sessions with potential applicants, labor unions, state and local governments, educational institutions and other stakeholders. 

The working group will also review all federal statutes and hiring authorities to remove any barriers to onboarding for the corps and standardize the practices across all participating agencies. Benefits for corps members will include housing, transportation, health care, child care, educational credit, scholarships and student loan forgiveness, stipends and non-financial services.

As part of the goal of the ACC, agencies will develop the corps so they can transition to “high-quality, family-sustaining careers with mobility potential” in the federal or other sectors. AmeriCorps CEO Michael Smith said the initiative would prepare young people for “good-paying union jobs.” 

Within three weeks of rolling out the ACC, EPA said more than 40,000 people—mostly in the 18-35 age range—expressed interest in joining the corps. The administration set an ambitious goal for getting the program underway, aiming to establish the corps’ first cohort in the summer of 2024. 

The corps members will work in roles related to ecosystem restoration and conservation, reforestation, waterway protection, recycling, energy conservation, clean energy deployment, disaster preparedness and recovery, fire resilience, resilient recreation infrastructure, research and outreach. The administration will look to ensure 40% of the climate-related investments flow to disadvantaged communities as part of its Justice40 initiative.  

EPA Administrator Michael Regan said the MOU would allow the ACC to “work across the federal family” to push public projects focused on environmental justice and clean energy. 

“The Climate Corps represents a significant step forward in engaging and nurturing young leaders who are passionate about climate action, furthering our journey towards a sustainable and equitable future,” Regan said. 

The ACC’s executive committee will hold its first meeting within the next 30 days. It will draw support from a new climate hub within AmeriCorps, as well as any staffing the agency heads designate."

-via Government Executive, December 20, 2023

-

This news comes with your regularly scheduled reminder that WE GOT THE AMERICAN CLIMATE CORPS ESTABLISHED LAST YEAR and basically no one know about/remembers it!!! Also if you want more info about the Climate Corps, inc. how to join, you can sign up to get updates here.

[neominthe]

SPOILERS FOR SCTIR FOR +CH 200

CW: (possibly) Eating disorder ED, depression

Something that keeps me awake at night: at the beggining of the story, Yoohyun's death isn't so painful for the viewers, because we only see what is on the surface of the Han brothers' life. It's through memories and flashbacks that we get to learn 3 facts: Yoojin dedicated his entire life to Yoohyun, they parted ways and in the end they reunited, only for one of them die. That's the introduction of SCTIR for us. Moreover, Yoojin is desesperate to leave the past behind, so he doesn't linger on his traumatic memories for too long, hence why the pain of reading SCTIR isn't instant.

It is gradual.

Yoojin and we learn that the past was never erased. It still happened, and exists in the form of Yoohyun's body out in the cold. Gradually, it becomes more apparent how Yoojin is still so affected by his previous life, despite his fear resistance skill. It starts with small things like him avoiding eating unless someone tells him to do so, always occupying himself with tasks that could be handled by someone else, negative thoughts about himself for every single action he takes and so on. I love, with all my heart, the manhwa, but the novel makes it so much more apparent how Yoojin loathes himself, to the point he keeps wishing he wasn't a human being, rather an item for his brother to use. It's so messed up to want to abandon all your humanity, feelings and concept of self just so you can be of help.

SCTIR is fun to read, but even more so with the unreliable narrator that is Yoojin. He sees what he does as nothing impressive, considering the people he is surrounded with, despite running the kisengsu facility, negotiating with the hair loss company to develop a new product, managing Seok Hayan's research team, mantaining diplomatic ties with Japan, training and helping other hunters and, most importantly, caring for all the S classes. He worries for their well-being because it's only natural for him to do so, as the Perfect Caregiver.

And, in the middle of it all, the only thing Yoojin spares for himself is hate. He doesn't want to live long for himself, but rather for Yoohyun, even though Yoojin already has been through the pain of loss. When Yoojin died in chapter 241, the first thing that he thought was Yoohyun. He didn't even think about how much it hurted dying (with a freaking shot on the head)! He just wanted to reunite and soothe Yoohyun that he was okay.

Speaking of which, in Sigma's arc, as Yoojin was alone, he really stopped caring for his well-being, so Sung Hyunjae took that role and did everything he could to help Yoojin. But, for him to even have to create a quest just so Yoojin could eat is what sparked my lizard brain to write this post.

My point is, there isn't an arc dedicated for recovery (at least until the chapter I have read that is like, ~300) and that is beautiful, because Yoojin is still processing what he went through, and we get to see that. Yoojin has such an interesting character arc as he begins wanting to forget the past, as it is too painful, to start running after it. He can't let go of it, because letting it go means letting his little brother go too. Which is why he says he will never be okay again in chapter 278.

[bitter-me]

A Blessing or A Curse?

Jing Yuan | M. Reader as Baizhu [Genshin Impact]

----------

"The doctor will see you now~"

----------

For centuries, immortality has been seen as a curse by the Xianzhou natives. An abomination.

How could they not? When they saw it with their own eyes, what immortality had brought to those who wished for it. How it changed them. Twist their minds until they're merely a shadow of their former self. What had become of those who got Mara-struck.

But...

Amongst those who look down on immortality with disdain. There's one who sees immortality as a blessing rather than a curse.

.

.

.

.

.

Hey, have you heard? There's a Doctor that could cure any illness! It's like a miracle! He works in a Pharmacy in the Alchemy Commission called, Bubu Pharmacy. The Doctor's name is—

"Doctor [Name]?"

"This new prescription, though not as fast-acting. Will allow gradual recovery and build-up of strength making it well suited to someone who's been suffering from a long illness. The needed ingredients can also be found around the Exalting Sanctum."

"Thank you, Doctor!"

The man thanked the doctor for the new prescription with a smile on hie face. The previous prescription used ingredients are hard to get in the district and now with the new prescription, finding the ingredients for the medicine would be a lot more easier.

He then left the pharmacy with the prescription in hand, leaving the doctor alone with his...

Snake.

"You actually found replacements for those ingredients." She says as she watched the man leave. "Of course, what kind of Doctor would I be if I couldn't?" He replied softly, his eyes scanning the documents in his hand.

----------

One day, Doctor [Name] have an unexpected visit.

"Ah, General! To what do I owe the honor of your visit? Are you perhaps injured?" The doctor greeted him with a faint smile on his face. Jing Yuan laugh at [Name]'s words. "No, Doctor. I'm perfectly healthy."

"That's good to hear." "He better be, or else our work would have been for nothing!!"

"Good to see you too Changsheng." The General chuckles. The snake huffs as she rested her body around [Name]'s shoulders. The two old friends sat at a nearby table, chatting away and catching up with one another.

For as long as he could remember, [Name] had always been a kind soul, ready to help at any given time despite being a short-life species. That didn't concern him at all as he studies medicine and the art of healing.

The day [Name] retuned with a white snake around his shoulder was the day that changed everything. For the Luofu and for his friends. Almost like a miracle, the people began to heal ad recover in a rapid pace. Thanks to the Doctor's treatment. They've began to wonder as to how that could be? A short-life species? Having an ability akin to a Vidyadhara? Impossible! And yet..

As [Name] continues to heal and treat his patients... the sicker he became..

It wasn't that it's noticeable, no.. far from it..

He appears as healthy as ever, although a few coughs and wheeze here and there but as an old friend of his, Jing Yuan can't help but show concern for the Doctor.

.

.

.

.

.

"Life, death... and the world around us all follow a set of laws... Hehe, but if you never test the limits, how can anyone know where the boundaries of these laws are?"

He should have known..

He should have known that.. his friend was..

..Researching on something forbidden..

How could this be...?

A kind and gentle man.. wanting nothing but to help and treat others.. began searching for the thing his motherland sought to destroy..? And he's been doing this from the starts..?

Why..? Why must he..

He felt betrayed. Betrayed by an old friend.

Immortality is a curse! Can't the Doctor see that! All of those soldiers, all of those people that were lost from it! Is he blind!! Why!? Why must he search for such abomination!!

And yet.. and yet...

His reason.. the Doctor's reason... [Name]'s reason...

..It's still pure..

He wanted to help.. to treat and heal others..

Changsheng.. her ability to heal is simply out of this world.. but the price.. the price that needs to be paid to do such an act.. isn't that just prove how terrible the power of Abundance is? And yet..

[Name] saw this as a blessing.

It's a gift.

A gift he'll accept with open arms.

Once he received immortality.. he could continue on to help others and.. he won't have to pass down the contract to anyone ever again..

His objective is simple...

To prevent suffering.

But.. is immortality truly the only way? To him, yes. As it would prevent any more people from dying young thanks to the contract. But to someone like Jing Yuan? The General of the Luofu? The man who had seen what immortality had done to others?

Is Immortality a blessing..? Or.. a curse..?

He doesn't know anymore.

[banj0possum]

Zombie Horde x AMAB transfem/gn reader who is working to find a cure for the zombie epidemic?

Like I was imagining reader works in a lab that is then overrun, and reader attempts to flee the horde or secretly continue their experiments when they aren’t looking.

Eventually maybe reader gets used to it and decides to take advantage of the “willing” and (usually) non-violent test subjects.

Love ur work btw <3

i havent given you guys your dose of zombie bitches lately so here ya go <3 this can be also be read as gn maybe

Zombie Horde x MtF!Reader Who's Looking for a Cure

CW: i will make you sob at the end istg, a bit of ewuh body stuff

💀 You've been trying to find a cure ever since the first wave of the epidemic, but the virus spread so quickly that you had to halt your research and flee the city, getting in your car after loading all your equipment and supplies in the trunk and driving off.

💀 Now, after just a few months, you were living in a symbiotic relationship with the very things you swore to destroy. At that point, you've forgotten all about the cure, thinking that there was no more hope on this earth for rehabilitation.

💀 But while lying down in your zombie husband pile at night, the idea sparked in your brain yet again, making you sit up, Ribs' head falling from your shoulder, waking him up.

💀 "S-sorry! So sorry Hun! Uhm..I gotta get something!" You pat Ribs' head before stumbling out of your bed, careful not to trip over the others. Bo blinks a bit before getting up and following you.

💀 You hear a low purr behind you as you were putting on your jacket and backpack and see Bo with a pleading, sleepy face. please come back..it's cold... you could imagine him saying. You chuckle and give him a kiss on the nose. "I'll be back, I promise!" and you run off outside to the parking lot.

💀 You retrieve your supplies from your old car, it's dusty and a bit dirty but the papers you've written were still readable.

💀 You carry the box of stuff back with you, Screw and Soda waiting for you and cocking their heads at the sight of their little mate carrying a box full of tubes and paper.

💀 The horde curiously watches you search through the papers, sometimes writing things down. You mumble soft words they didn't understand whilst looking over two or more papers.

💀 Eventually, you circle a string of letters and numbers and you hold your head in your hands with wide eyes, Screw crawls up to you cooing and you turn to him with the biggest smile on your face.

💀 "I think I got it.."

💀 He cocks his head with a chirp.

💀 "I have the cure..."

💀 You would've never considered it, but with your new discovery of visible consciousness in infected subjects, brain recovery and even bodily recovery can be possible, you just had to find a solution that can increase the body's constructive systems.

💀 You would forge for materials far beyond where you usually searched and would meet up with other survivors to exchange goods in order to conduct your research.

💀 Of course, your husbands were willing to help you, once you told them about your plan, they were so happy! Flesh like yours? Count us in! Ribs especially wants to help; he very much wants his torso back...

💀 The first tests weren't very fruitful but gave interesting results, one experiment with Bo included an injection to his arm, which made his heart beat for a few seconds before slowing and stopping like it was before.

💀 You would also see signs of growth, both Screw and Soda's wounds would appear to be healing themselves.

💀 After a few months of experimentation, you were starting to give up, the boys' wounds and lost body parts being unable to grow back.

💀 It was alright for you though, you never really expected to find the cure so easily, and you weren't sure if it could even work on other zombies.

💀 At least the boys looked a bit better than before though, their hair could grow like a human's and their limps were gone, their joints rejuvenated and no longer rigid, allowing them to move like a normal human and not a living corpse.

💀 You thought that was all that you got from your experiments when..

💀 "(Y-Y/N)?"

💀 That...voice? It sounds familiar somehow...

💀 "Babygirl? Can you hear me?" the voice says again, it was gruff with a bit of a southern accent.

💀 "That's not her name!" Another voice, more higher pitched that the first.

💀 "It's a nickname Ribs!" One quietly says.

💀 Your neck almost snaps at the speed you turned back.

💀 "Uhm..hey there babes.." Bo says awkwardly.

💀 Looks like their vocal chords grew back too...

[covid-safer-hotties]

also preserved on our archive

by Rowan Walrath

Public and private funding is lacking, scrambling opportunities to develop treatments

In brief Long COVID is a difficult therapeutic area to work in. It’s a scientifically challenging condition, but perhaps more critically, few want to fund new treatments. Private investors, Big Pharma, and government agencies alike see long COVID as too risky as long as its underlying mechanisms are so poorly understood. This dynamic has hampered the few biotechnology and pharmaceutical companies trying to develop new medicines. The lack of funding has frustrated people with long COVID, who have few options available to them. And crucially, it has snarled research and development, cutting drug development short.

When COVID-19 hit, the biotechnology company Aim ImmunoTech was developing a drug for myalgic encephalomyelitis/chronic fatigue syndrome, better known as ME/CFS. As more people came down with COVID-19, some began to describe lingering problems that sounded a lot like ME/CFS. In many cases, people who got sick simply never seemed to get better. In others, they recovered completely—or thought they had—only to be waylaid by new problems: fatigue that wouldn’t go away with any amount of rest, brain fog that got in the way of normal conversations, a sudden tendency toward dizziness and fainting, or all the above.

There was a clear overlap between the condition, which patients began calling long COVID, and ME/CFS. People with ME/CFS have a deep, debilitating fatigue. They cannot tolerate much, if any, exercise; walking up a slight incline can mean days of recovery. Those with the most severe cases are bedbound.

Aim’s leaders set out to test whether the company’s drug, Ampligen, which is approved for ME/CFS in Argentina but not yet in the US, might be a good fit for treating long COVID. They started with a tiny study, just 4 people. When most of those participants responded well, they scaled up to 80. While initial data were mixed, people taking Ampligen were generally able to walk farther in a 6 min walk test than those who took a placebo, indicating improvement in baseline fatigue. The company is now making plans for a follow-on study in long COVID.

Aim’s motivation for testing Ampligen in long COVID was twofold. Executives believed they could help people with the condition, given the significant overlap in symptoms with ME/CFS. But they also, plainly, thought there’d be money. They were wrong.

“When we first went out to do this study in long COVID, there was money from . . . RECOVER,” Aim scientific officer Chris McAleer says, referring to Researching COVID to Enhance Recovery (RECOVER), the National Institutes of Health’s $1.7 billion initiative to fund projects investigating causes of, and potential treatments for, long COVID. McAleer says Aim attempted to get RECOVER funds, “believing that we had a therapeutic for these individuals, and we get nothing.”

Instead of funding novel medicines like Ampligen, the NIH has directed most of its RECOVER resources to observational studies designed to learn more about the condition, not treat it. Only last year did the agency begin to fund clinical trials for long COVID treatments, and those investigate the repurposing of approved drugs. What RECOVER is not doing is funding new compounds.

RECOVER is the only federal funding mechanism aimed at long COVID research. Other initiatives, like the $5 billion Project NextGen and the $577 million Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, put grant money toward next-generation vaccines, monoclonal antibodies, and antivirals for COVID-19. They stop short of testing those compounds as long COVID treatments.

Private funding is even harder to come by. Large pharmaceutical companies have mostly stayed away from the condition. (Some RECOVER trials are testing Pfizer’s COVID-19 antiviral Paxlovid, but a Pfizer spokesperson confirms that Pfizer is not sponsoring those studies.) Most investors have also avoided long COVID: a senior analyst on PitchBook’s biotech team, which tracks industry financing closely, says he isn’t aware of any investment in the space.

“What you need is innovation on this front that’s not driven by profit motive, but impact on global human health,” says Sumit Chanda, an immunologist and microbiologist at Scripps Research who coleads one of the AViDD centers. “We could have been filling in the gaps for things like long COVID, where pharma doesn’t see that there’s a billion-dollar market.”

The few biotech companies that are developing potential treatments for long COVID, including Aim, are usually funding those efforts out of their own balance sheets. Experts warn that such a pattern is not sustainable. At least four companies that were developing long COVID treatments have shut down because of an apparent lack of finances. Others are evaluating a shift away from long COVID.

“It is seen by the industry and by investors as a shot in the dark,” says Radu Pislariu, cofounder and CEO of Laurent Pharmaceuticals, a start-up that’s developing an antiviral and anti-inflammatory for long COVID. “What I know is that nobody wants to hear about COVID. When you say the name COVID, it’s bad . . ., but long COVID is not going anywhere, because COVID-19 is endemic. It will stay. At some point, everyone will realize that we have to do more for it.”

‘Time and patience and money’ Much of the hesitancy to make new medicines stems from the evasive nature of long COVID itself. The condition is multisystemic, affecting the brain, heart, endocrine network, immune system, reproductive organs, and gastrointestinal tract. While researchers are finding increasing evidence for some of the disease’s mechanisms, like viral persistence, immune dysregulation, and mitochondrial dysfunction, they might not uncover a one-size-fits-all treatment.

“Until we have a better understanding of the underlying mechanisms of long COVID, I think physicians are doing the best they can with the information they have and the guidance that is available to them,” says Ian Simon, director of the US Department of Health and Human Services’ Office of Long COVID Research and Practice. The research taking place now will eventually guide new therapeutic development, he says.

Meanwhile, time marches on.

By the end of 2023, more than 409 million people worldwide had long COVID, according to a recent review coauthored by two cofounders of the Patient-Led Research Collaborative (PLRC) and several prominent long COVID researchers (Nat. Med. 2024; DOI: 10.1038/s41591-024-03173-6). Most of those 409 million contracted COVID-19 and then long COVID after vaccines and antivirals became available. That fact undercuts the notion that the condition results only from severe cases of COVID-19 contracted before those interventions existed. (Vaccination and treatment with antivirals do correlate with a lower incidence of long COVID but don’t prevent it outright.)

“There is that narrative that long COVID is over,” says Hannah Davis, cofounder of the PLRC and a coauthor of the review, who has had long COVID since 2020. “I think that’s fairly obviously not true.”

The few biotech companies that have taken matters into their own hands, like Aim, are often reduced to small study sizes with limited time frames because they can’t get outside funding.

InflammX Therapeutics, a Florida-based ophthalmology firm headed by former Bausch & Lomb executive Brian Levy, started testing an anti-inflammatory drug candidate called Xiflam after Levy’s daughter came down with long COVID. Xiflam is designed to close connexin 43 (Cx43) hemichannels when they become pathological. The hemichannels, which form in cell membranes, would otherwise allow intracellular adenosine triphosphate (ATP) to escape and signal the NLRP3 inflammasome to crank up its activity, causing pain and inflammation.

InflammX originally conceived of Xiflam as a treatment for inflammation in various eye disorders, but after Levy familiarized himself with the literature on long COVID, he figured the compound might be useful for people like his daughter.

InflammX set up a small Phase 2a study at a site just outside Boston. The trial will enroll just 20 participants, including Levy’s daughter and InflammX’s chief operating and financial officer, David Pool, who also has long COVID. The study is set up such that participants don’t know if they’re taking Xiflam or a placebo.

Levy says the company tried to communicate with NIH RECOVER staff multiple times but never heard back. “We couldn’t wait,” he says.

Larger firms are similarly disconnected from US federal efforts. COVID-19 vaccine maker Moderna appointed a vice president of long COVID last year. Bishoy Rizkalla now oversees a small team studying how the company’s messenger RNA shots could mitigate problems caused by new and latent viruses, including SARS-CoV-2. But Rizkalla says Moderna has no federally funded projects in long COVID.

Federal bureaucracy has slowed down research in other ways. When long COVID appeared, Tonix Pharmaceuticals was developing a possible drug called TNX-102 SL to treat fibromyalgia. The two conditions look similar: they’re painful, fatiguing, and multisystemic, and fibromyalgia can crop up after a viral infection.

But it wasn’t easy to design a study to test the compound in long COVID. Among other issues, the US Food and Drug Administration initially insisted that participants have a positive COVID-19 test confirmed by a laboratory, like a polymerase chain reaction test, to be included in the study. At-home diagnostics wouldn’t count.

“We spent a huge amount of money, and we couldn’t enroll people who had lab-confirmed COVID because no one was going to labs to confirm their COVID,” cofounder and CEO Seth Lederman says. “We just ran out of time and patience and money, frankly.”

Tonix had planned to enroll 450 participants. The company ultimately enrolled only 63. The study failed to meet its primary end point of reducing pain intensity, a result Lederman attributes to the smaller-than-expected sample size.

TNX-102 SL trended toward improvements in fatigue and other areas, like sleep quality and cognitive function, but Tonix is moving away from developing the compound as a long COVID treatment and focusing on developing it for fibromyalgia. If it’s approved, Lederman hopes that physicians will prescribe it to people who meet the clinical criteria for fibromyalgia regardless of whether their condition stems from COVID-19.

“I’m not saying we’re not going to do another study in long COVID, but for the short term, it’s deemphasized,” Lederman says.

Abandoned attempts Without more public or private investment, it’s unclear how research can proceed. The small corner of the private sector that has endeavored to take on long COVID is slowly becoming a graveyard.

Axcella Therapeutics made a big gamble in late 2022. The company pivoted from trying to treat nonalcoholic steatohepatitis, a liver disease, to addressing chronic fatigue in people with long COVID. In doing so, Axcella reoriented itself exclusively around long COVID, laying off most of its staff and abandoning other research activities. People in a 41-person Phase 2a trial of the drug candidate, AXA1125, showed improvement in fatigue scores based on a clinical questionnaire (eClinicalMedicine 2023, DOI: 10.1016/j.eclinm.2023.101946), but Axcella shut down before it could get its planned 300-person follow-on study up and running.

The fate of AXA1125 may be to gather dust. Axcella’s former executives have moved on to other pursuits. Erstwhile chief medical officer Margaret Koziel, once a champion of AXA1125, says by email that she is “not up to date on current research on long COVID.” Staff at the University of Oxford, which ran the Phase 2a study, were not able to procure information about the planned Phase 2b/3 trial. A spokesperson for Flagship Pioneering, the venture firm that founded Axcella in 2011, declined to comment to C&EN.

Other firms have met similar ends. Ampio Pharmaceuticals dissolved in August after completing only a Phase 1 study to evaluate an inhaled medication called Ampion in people with long COVID who have breathing issues. Biotech firm SolAeroMed shut down before even starting a trial of its bronchodilating medicine for people with long COVID. “Unfortunately we were unable to attract funding to support our clinical work for COVID,” CEO John Dennis says by email.

Another biotech company, Aerium Therapeutics, did manage to get just enough of its monoclonal antibody AER002 manufactured and in the hands of researchers at the University of California, San Francisco, before it ended operations. The researchers are now testing AER002 in a Phase 2 trial with people with long COVID. Michael Peluso, an infectious disease clinician and researcher at UCSF and principal investigator of the trial, says that while AER002 may not advance without a company behind it, the study could be valuable for validating long COVID’s mechanisms of disease and providing a proof of concept for monoclonal antibody treatment more generally.

“[Aerium] put a lot of effort into making sure that the study would not be impacted,” Peluso says. “Regardless of the results of this study, doing a follow-up study now that we’ve kind of learned the mechanics of it with modern monoclonals would be really, really interesting.”

‘A squandered opportunity’ In 2022, the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) put about $577 million toward nine research centers that would discover and develop antivirals for various pathogens. Called the Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, the centers were initially imagined as 5-year projects, enough time to ready multiple candidates for preclinical development. The NIH allocated money for the first 3 years and promised more funds to come later.

The prospect excited John Chodera, a computational chemist at the Memorial Sloan Kettering Cancer Center and a principal investigator at an AViDD center called the AI-Driven Structure-Enabled Antiviral Platform. Chodera figured that if his team were able to develop a potent antiviral for SARS-CoV-2, it could potentially be used to treat long COVID as well. A predominant theory is that reservoirs of hidden virus in the body cause ongoing symptoms.

But Chodera says NIAID told him and other AViDD investigators that establishing long COVID models was out of scope. And last year, Congress clawed back unspent COVID-19 pandemic relief funds, including the pool of money intended for the AViDD centers’ last 2 years. Lawmakers were supposed to come through with additional funding, Chodera says, but it never materialized. All nine AViDD centers will run out of money come May 2025.

“When we do start to understand what the molecular targets for long COVID are going to be, it’d be very easy to pivot and train our fire on those targets,” says Chanda from Scripps’s AViDD center. “The problem is that it took us probably 2 years to get everything up and going. If you cut the funding after 3 years, we basically have to dismantle it. We don’t have an opportunity to say, ‘Hey, look, this is what we’ve done. We can now take this and train our fire on X, Y, and Z.’ ”

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with additional funds. They now find themselves in the same position as many academic labs: seeking grant money to keep their projects going.

Worse, they say, is that applying for other grants will likely mean splitting up research teams, thus undoing the network effect that these centers were supposed to provide.

“Now what we’ve got is a bunch of half bridges with nowhere to fund the continuation of that work,” says Nathaniel Moorman, cofounder and scientific adviser of the Rapidly Emerging Antiviral Drug Development Initiative, which houses an AViDD center at the University of North Carolina at Chapel Hill.

“This was a squandered opportunity, not just for pandemic preparedness but to tackle these unmet needs that are being neglected by biotech and pharma,” Chanda says.

Viral persistence Ann Kwong has been here before. The virologist was among the first industry scientists trying to develop antivirals for hepatitis C virus (HCV) back in the 1990s. Kwong led an antiviral discovery team at the Schering-Plough Research Institute for 6 years. In 1997, Vertex Pharmaceuticals recruited her to lead its new virology group.

Kwong and her team at Vertex developed a number of antivirals for HCV, HIV, and influenza viruses; one was the HCV protease inhibitor telaprevir. She recalls that a major challenge for the HCV antivirals was that scientists didn’t know where in the body the virus was hiding. Kwong says she had to fight to develop an antiviral that targeted the liver since it hadn’t yet been confirmed that HCV primarily resides there. People with chronic hepatitis C would in many cases eventually develop liver failure or cancer, but they presented with other issues too, like brain fog, fatigue, and inflammation.

She sees the same dynamic playing out in long COVID.

“This reminds me of HIV days and HCV days,” Kwong says. “This idea that pharma doesn’t want to work on this because we don’t know things about SARS-CoV-2 and long COVID is bullshit.”

Since January, Kwong has been cooking up something new. She’s approaching long COVID the way she did chronic hepatitis C: treating it as a chronic infection, through a start-up called Persistence Bio. Persistence is still in stealth; its name reflects its mission to create antivirals that can reach hidden reservoirs of persistent SARS-CoV-2, which many researchers believe to be a cause of long COVID.

“Long COVID is really interesting because there’s so many different symptoms,” Kwong says. “As a virologist, I am not surprised, because it’s an amazing virus. It infects every tissue in your body. . . . All the autopsy studies show that it’s in your brain. It’s in your gut. It’s in your lungs. It’s in your heart. To me, all the different symptoms are indicative of where the virus has gone when it infected you.”

Kwong has experienced some of these symptoms firsthand. She contracted COVID-19 while flying home to Massachusetts from Germany in 2020. For about a year afterward, she’d get caught off guard by sudden bouts of fatigue, bending over to catch her breath as she walked around the horse farm where she lives, her legs aching. Those symptoms went away with time and luck, but another round of symptoms roared to life this spring, including what Kwong describes as “partial blackouts.”

Kwong hasn’t been formally diagnosed with long COVID, but she says she “strongly suspects” she has it. Others among Persistence’s team of about 25 also have the condition.

“Long COVID patients have been involved with the founding of our company, and we work closely with them and know how awful the condition can be,” Kwong says. “It is a big motivator for our team.”

Persistence is in the process of fundraising. Kwong says she’s in conversations with private investors, but she and her cofounders are hoping to get public funding too.

On Sept. 23, the NIH is convening a 3-day workshop to review what RECOVER has accomplished and plan the next phase of the initiative. Crucially, that phase will include additional clinical trials. RECOVER’s $1.7 billion in funding includes a recent award of $515 million over the next 4 years. It’s not out of the question that this time, industry players might be invited to the table. Tonix Pharmaceuticals’ Lederman and Aim ImmunoTech’s McAleer will both speak during the workshop.

The US Senate Committee on Appropriations explicitly directed the NIH during an Aug. 1 meeting to prioritize research to understand, diagnose, and treat long COVID. It also recommended that Congress put $1.5 billion toward the Advanced Research Projects Agency for Health (ARPA-H), which often partners with industry players. The committee instructed ARPA-H to invest in “high-risk, high-reward research . . . focused on drug trials, development of biomarkers, and research that includes long COVID associated conditions.” Also last month, Sen. Bernie Sanders (I-VT) introduced the Long COVID Research Moonshot Act, which would give the NIH $1 billion a year for a decade to treat and monitor patients.

It’s these kinds of mechanisms that might make a difference for long COVID drug development.

“What I’ve seen a lot is pharma being hesitant to get involved,” says Lisa McCorkell, a cofounder of the PLRC and a coauthor of the recent long COVID review. “Maybe they’ll invest if NIH also matches their investment or something like that. Having those public-private partnerships is really, at this stage, what will propel us forward.”

Chemical & Engineering News ISSN 0009-2347 Copyright © 2024 American Chemical Society

[heaven-s-black-box]

Permafrost- Wriothesley x fem!Reader

Return to File

Recovery date: July 27th, 2024

Description: Hello I was wondering if you could write a Wriothesley x female reader story where the reader is always a kind and gentle person and was there during Wriothesley's story quest

Notes: This work was recovered in conjunction with an anonymous researcher, we thank them for their contributions. This is pre-relationship, where Wrio and reader are kind of skirtting around their feelings.

Word count: 775

Back to directory

The Duke of the Fortress of Meropide rules with an Iron fist. Or an Iron gauntlet, perhaps? A frozen gauntlet! Sigewinne had laughed one day at lunch with Y/n. As the two nurses sorted through patient files, trying to find… neither remembers what. All that mattered was what the head nurse said next; But, you’re like the frozen ground hiding underneath. Before Y/n could ask for an elaboration, the Melusine offered her a bite of her lunch insisting she was too focused on the papers.

The Duke does not need to explain himself, he answers only to the court itself under the most dire of circumstances.

Wriothesley, answers to Y/n.

“Stop avoiding the question.”

Y/n stood between Wriothesly and his door, drawing the attention of nearby residents and guards. All eyes quickly passed over them though, as Wriothesly sent them warning glares before focusing back on the woman in front of him. She was holding the door behind her closed, even though he could easily over power her and open it.

He sighed. “Can we continue this conversation inside?”

“Of course, you know where the nurse’s office is. I’m sure Sigewinne will be happy to examine you,” Y/n chirped.

From anyone else the tone would have sounded sarcastic and sassy, but she made it sound so genuine. It was genuine.

That’s part of what irked him so much.

“Y/n.”

“Your grace.”

With a sigh, he continued forward until he towered over her and placed a hand on the door– trapping her in. He watched her weight shift so she was no longer leaning on the door, and then opened it.

Y/n slipped in, and he trailed behind with an order to the guards to not let anyone in unless it was an emergency.

The door closed with a resounding thud, and Wriothesly immediately found himself right back under her worried gaze. She barely had a chance to open her mouth, the sound of his name caught in her throat, as he scooped her into his arms.

Wriothesly buried his face in the crook of her neck, inhaling deeply.

“Wrio,” Y/n called softly, pulling his coat from his shoulders and letting it drop to the floor so she could rub his back, “are you okay?”

“I just need a second.”

Y/n could feel a faint shake in his hands where they rested against her waist. She’d heard what happened from the guards and the patients she’d just finished tending to, but she didn’t like hearing, she liked being told. She liked when Wriothesly opened up about what was going on in his head.

She moved one hand up to his hair and began carding her fingers through, twirling pieces and scratching at his scalp. The other rubbed soothingly at his back as her head fell against his and she listened to his breathing, feeling it warm her skin,

He takes a sudden deep breath and pulls away, dragging his hands along her waist like he doesn’t want to let go. Eventually his hands do leave her, and he clears his throat as he picks up his coat and drapes it over one arm.

“Thank you, I’m okay now.”

“I heard Dougier didn’t land any hits, but I wanted to make sure you weren’t just hiding things.”

Wriothesely scoffed, “Like he could get a hit off on me.”

“He had a gun.”

“And I didn’t get shot.” Y/n sighed, rolling her eyes fondly. “Now, if that’s all, I’m sure you have much to do.”

Y/n frowned. “I should probably start looking for a way to remove those thorns…”

“Let me know if there’s anything I can do to help.”

“Of course.”

Y/n didn’t move, and neither did the Duke, as the silence bled into the room. The sounds of the fortress faintly filtered through the cracks in the door, but even they weren’t enough to stave off the atmosphere that grew.

“I’m glad you’re okay,” Y/n said finally. “I’ll be off now, if you need me you know where to find me.”

She bowed. When she started for the door, Wriothesly jumped into action, beating her there and holding it open.

“Thank you for your concern, I’ll be sure to look for you if anything comes up.”

“Goodbye, your grace.”

“Goodbye, Y/n.” 

He waved, even though she was no longer watching him, before shutting himself back in his office, all the while Sigewinne watched from the hall to the nurse’s office.

The Duke reigned with a frozen gauntlet, cool and strong, and just below that ice was a grassy land holding it up.

[h0neysp1ce]

Hello, Saw your request open, Can I request fluff Headcanons, (Tighnari, Cyno and Gaming) how they would take care of Sick s/o, but here's the thing, she has anemia so it takes longer for her to get better.

(This is basically me just seeking out comfort from my fav characters because I'm currently sick lol)

Fʅυϝϝ Hҽαԃ ƈαɳσɳʂ

Summary: How does he take care of s/o when she's sick?

°❀⋆.ೃ࿔*:･ Characters: Tighnari, Cyno, Fem! Reader Tags: Established Relationship, Fluff Constellation: Head canons Warning(s): Mentions of sickness, nothing too graphic or detailed, mentions of reader being Anemic, mentions of anemia symptoms, just general illness/sickness mentions. Reader Is fem! alined uses of the word Girlfriend. °❀⋆.ೃ࿔*:･

A/N: Hello Anonie, I'm so sorry to hear that :( I hope this brings you comfort, get well soon 💛

Extra Side Note: Also I did a little research on Anemia to help write this, I hope it's not too scuffed . (Edited Post)

Word count: 1139

⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆

Tιɠԋɳαɾι 🌻

He had been aware of your anemia since you first met, so he was always prepared for when you might become ill.

He would keep plenty of herbs and remedies on hand to ease your sickness and discomfort, especially since it tended to take longer for you to recover.

He’d make you soup (specifically a vegetable type ) or prepare foods rich in iron, as anemia results in low iron deficiency.

The moment he noticed a hint of illness, he’d immediately have you sit down or lie down, especially if you mentioned feeling dizzy or weak.

Since you’d often have cold hands due to your condition, he had a habit of interlocking his hands with yours and warming your hands with his. He did this often when you weren’t feeling well, and it was incredibly comforting. You soaked up his warmth as much as you could.

Your symptoms ranged from dizziness and tiredness to general weakness. Tighnari was more than prepared to take care of you and attend to your needs.

He’d give you forehead kisses, always hold your hands, and place kisses on them every now and then.

He’d have you cuddle up to him for warmth, holding you close while you slept or simply throughout the day.

He frequently checked up on you, asking how you were feeling. He wanted you to be upfront and honest; your well-being meant everything to him.

If your condition worsened, he’d take you to the Bimarstan for more advanced treatment if his remedies weren’t effective.

He’d always brew some herbal tea or another type of tea when you felt an illness coming on. That was his first line of defense.

He wouldn’t let you get up from bed because of your condition. It was imperative that you stay put and avoid straining yourself.

He wanted you to take it easy throughout your long recovery.

He’d get you anything you needed if you asked, so don’t be shy about making requests.

He always reassured you that he was there for you.

He had a habit of cupping your chin and the sides of your face with his hands. Not in a negative way, but because he considered you his delicate flower, needing to be taken care of with utmost care.

It pained him to see you unwell, and he’d do anything to alleviate your discomfort- even trade places with you if he could.

You’d scold him when he leaned in to kiss you, warning him that he might get sick from you. He’d always insist he’d be fine.

He would definitely shower you with love throughout your illness, not just by taking care of you but also by giving you loads of affection and attention.

If you were tired, he’d have you rest, and he’d wake you up periodically to ensure you took your medication, ate before taking it (as medicine on an empty stomach isn’t ideal), and stayed hydrated. If you allowed him, he’d even feed you himself.

He always kept extra blankets on hand for you and would wrap you up in them for sure.

Cყɳσ 🌙

He’s knowledgeable about your condition, and when you’re ill, he’s prepared for the most part.

If you’re up and about and start to feel dizzy or experience a spell, he’ll be right by your side to prevent you from fainting and hurting yourself.

His arms will be wrapped around your middle to support you if you do faint.

If you insist on doing things yourself, he’ll agree, but only if you let him carry you to where you need to go (ex: living room, kitchen).

He’s always one to kiss your inner wrists when you’re unwell, as a form of comfort.

Though his hands are calloused from wielding a spear, they’re comforting when he draws small circles on the back of your hands.

He doesn’t mind kissing you while you’re sick; nothing will stop him from loving you and giving you the care you deserve.

When you both lay down, you’d be on top of him with his arms wrapped around your lower back. Sometimes, if you want, he might rub circles on your back to help you fall asleep and might even tell you jokes as you drift off.

He’d try to limit his duties as General Mahamatra to stay by your side when you’re ill. He wouldn’t leave you unattended.

In the morning, while you’re still recovering, he might wake you up with a kiss on the cheek or a soft whisper that it’s time to get up (likely to take meds, eat, and drink something).

If you fall asleep before him, he’d gently run his hand across your forehead, combing through your hair, slightly frowning as he hates seeing you in pain or discomfort.

As your boyfriend, he loves you immensely and would do anything for you.

He’d let you sit sideways on his lap whenever you wanted and lean into him. No matter if you’re sick or not, he finds you to be the prettiest woman he’s ever known, even in sickness.

⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆ ⋆ ˚｡⋆୨♡୧⋆ ˚｡⋆

[hufflepuffwritingstuff2]

Whumptober 2024 No. 28 Altprompt- Venom

I had to do so much research for this snippet guys, I really hope you like it!

“And this, my dear Hero, is where I keep my babies,” Villain said, opening a large metal door.

Hero followed them outside, astounded to see what looked like a mix between a zoo and a wildlife center. All kinds of exotic animals prowled about in enormous enclosures.

“Is this what you spent that stolen bank money on?” Hero asked in awe.

“Maybe~” Villain sang.

Villain strolled up to a tiger and petted it, the tiger purred loudly.

“Who’s a good boy, you are!” Villain cooed.

Hero kept their distance; they didn’t want to be tiger meat. Villain beckoned them over.

"He won’t bite,” Villain promised, “unless you’re a raw steak of course.”

Hero gulped, coming over. The tiger sniffed Hero’s hand, then pressed its head into it, purring. Hero stared slack-jawed as they stroked its fur.

“Aw, he likes you!” Villain smiled.

Villain showed Hero a number of other animals, all of which were rescued in some way or another and unfit to return to the wild. A scarlet macaw, a European badger, a very tiny species of deer. Suddenly, Villain’s face fell.

“Oh no,” they said, “not again.”

“What’s wrong?”

“My platypus,” Villain said, “he’s run off again.”

“Maybe he had to fight Dr. Doofenshmirtz,” Hero joked.

“Oh, this is no laughing matter, you have no idea what Percy is capable of.”

“What do you mean- AUGH!”

Something pinched their ankle, and Hero dropped to the ground, clutching it for dear life as electrifying pain exploded through it.

“Hero!” Villain shouted.

Villain bent down and picked up the offending animal; it was none other than Percy the platypus.

“No sir!” Villain scolded, putting Percy back in his home, “we do not sting people!”

“That thing is venomous!?” Hero screeched through the pain.

“Well, yes,” Villain said between Hero’s screams, “stay there, I have what you need.”

Villain ran to a cabinet near Percy’s enclosure. They pulled out a vial labeled “nerve-blocker” and a syringe. Filling it, they ran back to Hero’s side.

“Shh, I know, I know,” Villain soothed, “it’ll be over soon, I promise.”

Villain pulled up Hero’s pant leg and examined the wound. Their ankle was already quite swollen. Villain injected the contents of the syringe right into the envenomation site. After a few minutes, Hero’s screams died down to little whimpers.

“Why,” they panted, “do you have… that… in your collection!?”

“Percy can’t swim,” Villain said, “he wouldn’t make it very long in nature. I’ve gotten my fair share of stings from him. I’m just sorry you had to experience it. He is a bit skittish around visitors.”

Hero went to stand, but Villain stopped them.

“You won’t be able to walk for a few weeks,” Villain said, “I need to have you on nerve-blockers around the clock.”

“WHAT!?”

“Your symptoms won't subside until then, and you might still have trouble for a few months after that. Fortunately, I am delveoping an antivenom. I’ve been studying Percy’s venom and I think I almost have it down.”

“Wait… there’s no antivenom!?”

“No, but there will be as soon as I finish it,” Villain smiled awkwardly.

Hero couldn’t even feel their ankle now, which was far better than the last minute and a half, but that meant no heroics or anything at all really for some time.

“I’ll take care of you, Hero,” Villain said, seeming to read their thoughts.

Villain picked Hero up in a bridal carry and took them from the site, back inside their lair. They brought them up to a guest room and laid them down in a bed.

“I’ll get all the medical equipment hooked up to you,” Villain said, “and then we’ll talk about the recovery plan, okay?”

Hero nodded, their adrenaline wearing off and giving way to shock. In all of their fights, they had never felt pain like that. Percy was suddenly far more terrifying than any supervillain.

Patreon

Ko-Fi

Redbubble

Tags:

@mythixmagic @infinityshadows @fishtale88 @thelazywitchphotographer @the-beasts-have-arrived @princessofonwardsworld @surplus-of-sarcasm @memepsychowhowantsuperpower-blog

@electrons2006 @just-a-space-rabbit

[dark-audit]

Things I wish more writers understood about PTSD

Traumatic events don't always lead to PTSD. Two people can experience the exact same traumatic event, and one can go to work the next day shaken up but otherwise alright, while the other still has trouble functioning normally two years down the line. This is a fact that's been studied to death in psychology, but we're still no closer to figuring out why this discrepancy exists. So no, that character who experienced a very traumatic event and wasn't traumatized to your liking wasn't actually 'unrealistic'; they just didn't live up to your preconception of how trauma is supposed to effect people.

There is no flaw or 'weakness' in a person's temprament or personality construction that will make them more likely to develop PTSD, and likewise, people who don't develop PTSD are not inherently 'tougher'. PTSD is not the kind of illness you can blame on the person who suffers from it; human beings are more complicated than that. Furthermore, people who don't develop PTSD from a traumatic event exist, in fact they're very common, and while they don't develop that precise, largely arbitrary set of symptoms, they are still likely to be deeply affected by the event/s. Their experiences are no less real than those of their counterparts.

Sometimes, a person who experienced a traumatic even didn't develop PTSD afterwards - because they already had it. There are lots of people who go into therapy following a traumatic event only to discover they've been experiencing the symptoms of PTSD for years, following a previous unrelated traumatic event. This is especially common for people who had C-PTSD beforehand. Since PTSD can often manifest in very subtle ways, and since people are likely to 'mask' symptoms as a way to keep judgement or prying at bay, this scenario is not particularly uncommon.

PTSD doesn't always develop immediately following the traumatic event. PTSD can take any amount of time to develop. For most people, it takes around 3 months for symptoms to appear, but for a lot of people, the symptoms of PTSD do not appear for many months, even years after the event/s. This usually has something to do with the memory issues that can arise after trauma, and also might be affected by how a person conceptualizes the 'threat level' over time.

People with PTSD are not 'broken'; people with PTSD can be treated. Human beings aren't inanimate objects; we're living beings, graced with this incredible ability to adapt, grow and change. While there is no 'cure' for PTSD, there are loads of types of psychotherapy and medications that help to alleviate symptoms, and many people with this disorder are able to live fulfilling lives despite the diagnosis. Recovery is never out of the question, no matter how severe a person's symptoms might be. PTSD or not, I for one have yet to encounter anyone I would ever consider irrevocably 'broken'.

People with PTSD don't all experience the same symptoms. I feel like it needs to be said, because there is a bit of a 'type' in fiction, isn't there? And this can be incredibly disheartening to read for someone whose PTSD doesn't align with the way it is constantly shown to 'normally' manifest. In reality, PTSD is a very complex disorder, which might express itself in a wide breadth of different ways, and people handle their symptoms using a wide breadth of different methods. You'd be hard pressed to find two people who are completely alike in this regard.

Perpetrators of violence are just as likely to develop PTSD as their victims. This is one of those things I learned though my torture research escapades, and I've found it applies to other violent crimes as well, such as violent assault and murder. It's not a particularly nice fact to know if you want to maintain your straightforward good-vs-evil worldview, but alas, the real world is grim and complicated. There is actually a name for this type of PTSD, and it is Participation-Induced Post Traumatic Stress Disorder (PI-PTSD), or perpetrator trauma. PTSD does not discriminate, and you're not safe from it just because you're not on the recieving end.

People with PTSD aren't automatically more violent. I don't know why this myth has to be so prominent with every single mental illness ever, but like, yeah, its not true for this one either.

[theotherwesley]

Here is what I am learning: Sometimes, one finds oneself in the unenviable position of being, say, in one's 30's, looking back at work you did when you were 19, or at work from current talented 19 year olds, and thinking "wow, why is this better than the stuff I've been struggling to do during a long dry spell?" There is nothing particularly unique about being a young adult (except maybe energy/time) that makes a person good at doing stuff they're working hard at. At 19 many people, probably including yourself, were in college, amongst peers, being exposed to new things, making cross-disciplinary connections, thinking critically, practicing with the intent of improving, actively using your brain and building synapses, and ideally being encouraged to do so while in a stable environment. The missing ingredient is not Youth or Talent-- it's regular brain exercise and not trying to be creative in a vacuum. Your brain can start working out at any time, it's not stuck where it is. Read long stuff, research something that interests you, engage with a topic outside of your current level expertise that you have to work to understand, watch something older than you are, talk to someone on a regular basis, practice something without the intent to share it. Don't try to do it all overnight. Sleep on it. The flexibility comes back, I promise. It's a recovery process and works the same as any other recovery process.

[parasupport]

Para / 🥄 Support Resources (and intro)

emoji code used: here I am always looking for more resources, please send them in, especially if they're non-🗺️ resources

Generally Applicable:

⤸ Find a helpline ⤸ Your closest help centre ⤸ Find therapy ⤸ 🥄Carrd ⤸ 🥄Disorders

🗺️

⤸ Therapy tips for 🗺️s and here (applies to other paras too)

⤸ Other 🗺️-focused organisations, websites, and services: B4U-Act, Path2Prevention, StopItNow, ASAP International, VirPed, Global Prevention Project ⤸ B4U-Act also has a forum: bB4um ⤸ 🗺️Support Club - Prostasia Foundation

⤸ A 🗺️'s Journey (podcast) and 🗺️Accuracy (blog) specialised episodes: (1) benefits and challenges of therapy, (2) age dysphoria, (3) female 🗺️s, (4) transgender 🗺️s, (5) recovery after offending, (6) recognising and stopping grooming, (7) parenthood as a 🗺️, (8) working with children as a 🗺️, (9) supporting minor 🗺️s

⤸ 🗺️resources.info (support groups, guides, research, volunteering, etc. Also has help for🗺️CSA survivors, minor 🗺️s, P-OCD, and more) ⤸ further resources ⤸ and more resources ⤸ 🗺️Misconceptions

Personal Intro

Hello, you can call me Wraith (no pronouns or he/him if you must)

I'm a psychology and counselling graduate, panpara / omniphile, and non-contact 🗺️tivist and para activist. I have experience volunteering for 🗺️ organisations like the ones I've listed and providing peer support for fellow -philes, which I'd love to do here if Tumblr so allows it

I also have experience with receiving therapy as a minor and young adult for a para disorder. I've since gotten a lot better and no longer meet the critera for said disorder, but still receive therapy because it's tough being in this situation when society sees you as a danger

I use transids and identify as transeverything myself - currently looking into dissomei identities but not sure about switching yet I have schizoaffective disorder and experience delusions

Tags do not necessarily reflect my identity, I'd just rather this post access the people it needs to